Gemoscan Canada Announces Shares for Service Agreement

Gemoscan Canada, Inc. ("Gemoscan" or the "Company") (TSX VENTURE:GES)(MUN:1GE)
announces its intention to issue shares for services to a consultant of the
Company in exchange for the provision of certain strategic advisory services
("Advisory Services").


Gemoscan has entered into an agreement with the consultant to provide such
Advisory Services (the "Agreement"). Pursuant to the terms of the Agreement, the
Company will be issuing CAD$4,500.00 in Class A common shares of the Company per
month in exchange for the Advisory Services. The number of shares to be issued
shall be determined by using the closing price of the shares on the TSX Venture
Exchange on the first trading day of the month following the month for which
services were rendered.


The initial term of the Agreement is six months in duration and the Company
expects the first issuance of shares under the Agreement to occur on June 7,
2012.


The provisions of this Agreement are subject to final approval by the TSX
Venture Exchange and to compliance with all applicable regulatory requirements.


ABOUT GEMOSCAN CANADA, INC.

Gemoscan is an industry leader in food intolerance management and maintains a
first- to-market position with Canada wide distribution through select retail
partners. Founded in 2003, using its proprietary patented technology Gemoscan
develops, owns and markets comprehensive food sensitivity and dietary management
solutions for consumers, including the HEMOCODE(TM) Food Intolerance System, a
personalized naturopathic nutritional program that promotes well-being. Gemoscan
is the first and only provider to commercialize a food intolerance management
solution directly to consumers in partnership with retailers, and today offers
the most comprehensive services available.


Gemoscan Canada, Inc. trades its shares on the Toronto Venture Exchange (TSX
VENTURE) under the symbol GES and is quoted on the Munich, Frankfurt and
Stuttgart Stock Exchanges under the symbol 1GE.


Forward-Looking Information

This news release contains certain "forward-looking information". All
statements, other than statements of historical fact that address activities,
events or developments that Gemoscan believes, expects or anticipates will or
may occur in the future. These forward-looking statements reflect the current
expectations or beliefs of Gemoscan based on information currently available to
Gemoscan. Forward-looking statements are subject to a number of significant
risks and uncertainties and other factors that may cause the actual results of
Gemoscan to differ materially from those discussed in the forward-looking
statements, and even if such actual results are realized or substantially
realized, there can be no assurance that they will have the expected
consequences to, or effects on Gemoscan. Any forward-looking statement speaks
only as of the date on which it is made and, except as may be required by
applicable securities laws, Gemoscan disclaims any intent or obligation to
update any forward-looking statement, whether as a result of new information,
future events or results or otherwise. Although Gemoscan believes that the
assumptions inherent in the forward-looking statements are reasonable,
forward-looking statements are not guarantees of future performance and
accordingly undue reliance should not be put on such statements due to the
inherent uncertainty therein.

Gemoscan Canada, Inc. (TSXV:GES)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024